Project
Anti-PD-L1 antibody MEDI4736 in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial.
Completed - recruitment closed · 2016 until 2024
Frueh Martin, Breuss Kim, Quinter Janine
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed - recruitment closed
Start Date
2016
End Date
2024
Financing
SAKK
Labels
lung cancer